More articles from 05.01 - Airway pharmacology and treatment

The antiasthmatic activity of Rho-kinase inhibitor hydroxyfasudil in the settings of experimentally induced allergic airway inflammation
S Franova, M Molitorisova, L Kalmanova, J Palencarova, M Sutovska

European Respiratory Journal Sep 2022, 60 (suppl 66) 4516; DOI: 10.1183/13993003.congress-2022.4516
Impact of erdosteine on exacerbations in moderate COPD
P M A Calverley, A Papi, C Page, P Rogliani, R Dal Negro, M Cazzola, A Cicero, W Wedzicha

European Respiratory Journal Sep 2022, 60 (suppl 66) 4365; DOI: 10.1183/13993003.congress-2022.4365
Safety of ascending single and multiple doses of inhaled SIS, an isotonic aqueous solution of sodium hypochlorite, in healthy subjects
C Burton, T Balchen, L Wilki-Kurtzhals, N Sjögren, T Bjarnsholt, E Jørgensen, D P Sonne

European Respiratory Journal Sep 2022, 60 (suppl 66) 4333; DOI: 10.1183/13993003.congress-2022.4333
Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
A A Yorgancıoğlu, I Pavord, G Brusselle, P Pitrez, S Oosterholt, A Pg, O Della Pasqua

European Respiratory Journal Sep 2022, 60 (suppl 66) 4572; DOI: 10.1183/13993003.congress-2022.4572
A case of excavated pneumopathy after bronchial thermoplasty
M Steger, N Khayath, M Ohana, N Migueres, C Marcot, F De Blay, N Migueres

European Respiratory Journal Sep 2022, 60 (suppl 66) 4216; DOI: 10.1183/13993003.congress-2022.4216
ETD001: A long-acting inhaled ENaC blocker, is well tolerated in humans
P Russell, K Woodward, J Charlwood, R White, D Wilkes, H Danahay, D Morris

European Respiratory Journal Sep 2022, 60 (suppl 66) 4338; DOI: 10.1183/13993003.congress-2022.4338
A phase 3b, randomized controlled trial of gefapixant in recent-onset chronic cough
L McGarvey, M Sher, Y Grigorievich Shvarts, S Lu, W Wu, P Xu, J Schelfhout, C La Rosa, A Martin Nguyen, P Reyfman, A Sadaf Afzal, L McGarvey

European Respiratory Journal Sep 2022, 60 (suppl 66) 4422; DOI: 10.1183/13993003.congress-2022.4422
Metformin: A potential drug candidate to restore poor corticosteroid sensitivity in obese asthmatic patients
M To, N Honda, K Haruki, Y To

European Respiratory Journal Sep 2022, 60 (suppl 66) 4344; DOI: 10.1183/13993003.congress-2022.4344
The perspective of clinical pharmacologist: what is the safety of complex polypharmacy in hospitalized COVID-19 patients?
O Kovalenko, V Rudakova, K Suska, K Gashynova, N But

European Respiratory Journal Sep 2022, 60 (suppl 66) 4200; DOI: 10.1183/13993003.congress-2022.4200
Effects of anti-tryptase antibody in upper and lower airway of asthmatics
L Henderson, K Wong, V Poon, G Sperinde, R Bauer, K Yoshida, C Chen, Q Liu, Y Chen, K Long, P Banerjee, S Laing, N Jones, H Rhee, B Leaker, D Singh, P Bradding

European Respiratory Journal Sep 2022, 60 (suppl 66) 4436; DOI: 10.1183/13993003.congress-2022.4436

Main menu

User menu

Search

More articles from 05.01 - Airway pharmacology and treatment

Pages

Contact us